These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 26985913)

  • 1. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
    Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
    Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
    Keller B; Braathen LR; Marti HP; Hunger RE
    Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
    Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: a single-center experience in São Paulo, Brazil.
    Hayashida MZ; Fernandes VM; Fernandes DR; Ogawa MM; Tomimori J
    Int J Dermatol; 2015 Oct; 54(10):e383-8. PubMed ID: 25969871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients.
    Murray SL; Daly FE; O'Kelly P; O'Leary E; Deady S; O'Neill JP; Dudley A; Rutledge NR; McCormick A; Houlihan DD; Williams Y; Morris PG; Ni Raghallaigh S; Moloney FJ; Sexton DJ; Conlon PJ
    Ren Fail; 2020 Nov; 42(1):607-612. PubMed ID: 32605413
    [No Abstract]   [Full Text] [Related]  

  • 7. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
    Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
    J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
    Ng JC; Cumming S; Leung V; Chong AH
    Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors of non melanoma skin cancers in kidney transplant patients].
    Sułowicz J; Wojas-Pelc A; Ignacak E; Betkowska-Prokop A; Kuzniewski M; Sułowicz W
    Przegl Lek; 2014; 71(1):19-25. PubMed ID: 24712264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview on non-melanoma skin cancers in solid organ transplant recipients.
    Forchetti G; Suppa M; Del Marmol V
    G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia.
    Iannacone MR; Sinnya S; Pandeya N; Isbel N; Campbell S; Fawcett J; Soyer PH; Ferguson L; Davis M; Whiteman DC; Green AC;
    J Invest Dermatol; 2016 Jul; 136(7):1382-1386. PubMed ID: 26968258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
    Bernat García J; Morales Suárez-Varela M; Vilata JJ; Marquina A; Pallardó L; Crespo J
    Acta Derm Venereol; 2013 Jul; 93(4):422-7. PubMed ID: 23303600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.
    Pinho A; Gouveia M; Cardoso JC; Xavier MM; Vieira R; Alves R
    An Bras Dermatol; 2016; 91(4):455-62. PubMed ID: 27579740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
    Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
    Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
    Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
    Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients.
    Oliveira WRP; Tirico MCCP; Souza AAV; Codarin FR; Silva LLC; Festa Neto C
    Int J Dermatol; 2019 Apr; 58(4):440-448. PubMed ID: 30565651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
    Tessari G; Girolomoni G
    Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
    De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
    JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients.
    Opelz G; Unterrainer C; Süsal C; Döhler B
    Nephrol Dial Transplant; 2016 Aug; 31(8):1360-7. PubMed ID: 27190384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.